FMRP silencing via siRNA lipid nanoparticles to reprogram the tumor microenvironment and enhance anti-PD-1 efficacy in triple-negative breast cancer
Fragile X mental retardation protein (FMRP), encoded by the Fmr1 gene, is notably upregulated in various malignancies, including triple-negative breast cancer, pancreatic ductal adenocarcinoma, and colon carcinoma, and potentially mediates immune evasion through multiple mechanisms. Here a small int...
Saved in:
Main Authors: | Letian Bai, Xinyan Hao, Wenjie Xu, Hai Huang, Mengen Guo, Yanwen Zhang, Daxiong Xiang, Guoping Yang, Junyong Wu, Chuanpin Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-08-01
|
Series: | Materials Today Bio |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590006425006453 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
<i>FMR1</i>: A Neurodevelopmental Factor Regulating Cell Metabolism in the Tumor Microenvironment
by: Renbin Zhou, et al.
Published: (2025-05-01) -
A systemically deliverable lipid-conjugated siRNA targeting DUX4 as an facioscapulohumeral muscular dystrophy therapeutic
by: Katelyn Daman, et al.
Published: (2025-09-01) -
Nanomolecular silencing of TSC22D4 mRNA via a DNAsome-siRNA for enhancing insulin sensitization in hepatocytes
by: Ameneh Mohammadi, et al.
Published: (2025-03-01) -
First Russian experience of treating dyslipidemia with siRNA drugs in patients after heart transplantation
by: M. A. Simonenko, et al.
Published: (2024-02-01) -
Small Interfering RNA (siRNA) in Dyslipidemia: A Systematic Review on Safety and Efficacy of siRNA
by: Alla SSM, et al.
Published: (2025-05-01)